Ignite Creation Date:
2025-12-25 @ 4:56 AM
Ignite Modification Date:
2025-12-26 @ 3:55 AM
Study NCT ID:
NCT03764618
Status:
COMPLETED
Last Update Posted:
2023-05-25
First Post:
2018-12-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA
Sponsor:
Rigel Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-11
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-03
First Submit QC Date:
None
Study First Post Date:
2018-12-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-29
Results First Submit QC Date:
None
Results First Post Date:
2023-05-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-23
Last Update Post Date:
2023-05-25
Last Update Post Date Type:
ACTUAL